MediPoint: Nuclear Imaging- PET and SPECT Equipment - Global Analysis and Market Forecasts

MediPoint: Nuclear Imaging- PET and SPECT Equipment - Global Analysis and Market Forecasts is a new market research publication announced by Reportstack. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine.
The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets.
PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report. PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs. PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used. PET/CT is most often used for cancer diagnosis.
PET/MRI is a new technique that was introduced to reduce patient exposure to radiation
PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT
SPECT imaging uses Gamma Emitting radioactive tracers with a longer half life, to image molecular processes in the body
SPECT and SPECT/CT are most often used in cardiology studies
The SPECT and SPECT/CT market is a bigger market than the PET, PET/CT and PET/MRI, because the instruments have been in longer use, are cheaper, and have become the common technique for a wide range of indications
Physicians believe more and more SPECT procedures will be replaced by PET procedures
New developments in hybrid nuclear imaging promise to further increase the utility of hybrid nuclear imaging, while significantly improving patient cost-savings and safety, through reduced need for repeat examinations.
This report focuses on the current and future industry trends within the nuclear medicine market, as well as discussing the promising pipeline products, and assessing the competitive landscape.

Questions Answered in this Report
What is the current and future nuclear imaging market outlook in the developed and emerging markets? What trends are affecting the global market for both SPECT and PET imaging systems?
Which are the key, high growth markets that manufacturers should seek to expand into? What are the types of products that are most likely to succeed?
How many Nuclear Imaging Procedures are carried out in each of the 10 Major Markets? What does this imply for instrument adoption rates?
What are the major unmet needs in nuclear imaging? In which areas can manufacturers help meet that need?
What factors most influence a physician or hospital in the purchase of new nuclear imaging equipment? How much can a physician influence purchasing decisions?
How will reimbursement changes will affect nuclear imaging. How has the Affordable Care Act affected nuclear imaging? How will it affect it in the future?
How well are new paradigms in nuclear imaging perceived? What motivates companies to develop a new nuclear imaging modality; physician demand or legislative requirement?
Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India

Market Model Features
Nuclear Imaging is a moderately growing market, with a CAGR of 3.3% for the period to 2020 
PET/CT, SPECT, SPECT/CT and Scinitgraphy are the major techniques in nuclear imaging 
US dominates the world market for nuclear imaging equipment 
US will see lowest growth in nuclear imaging equipment thanks to reimbursement pressures 
Japan and China will present the greatest opportunities for growth, with respective market shares increasing by 75% and almost 100% during the forecasted period 
BIC nations will experience the highest growth rates in nuclear imaging equipment during the forecast period 
Non-PET nuclear imaging procedures in the developed markets (US, 5EU, Japan) likely overall to fall during forecast period, as a result of increasing reimbursement pressures and new technologies 
PET imaging procedures in all markets likely to increase during the forecast period, despite reimbursement pressures, due to increased number of indications

What Physicians Think
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline in the fields of PET/CT, PET/MRI and SPECT/CT. 
Develop business strategies by understanding the trends shaping and driving the nuclear imaging market 
Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the nuclear imaging market in the future 
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors 
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage 
Track device sales in the global and country-specific nuclear imaging markets from 2012-2020 
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships 

List of Companies
DDD-Diagnostic
Digirad
GE Healthcare
GVI Medical Devices
Mediso Medical Imaging Systems
Neurologica
Neusoft Medical Systems
NuCare Medical Systems
Oncovision
Philips Healthcare
Shimadzu
Siemens Healthcare
SurgicEye
Toshiba Medical
Brain Biosciences
CardiArc
CMR Naviscan
FMI Technologies
Intramedical Imaging
NIPK Electron
Photo Diagnostic Systems
Positron
Shanghai United Imaging Healthcare
Spectrum Dynamics
SynchroPET
Zecotek PhotonicsTo view the table of contents and know more details please visit MediPoint: Nuclear Imaging- PET and SPECT Equipment - Global Analysis and Market Forecasts